Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

BVS Company Profile and Key Details

NASDAQ : BVS

Bioventus Inc.

$7.50
-0.32-4.09%
At Close 4:00 PM
68.4
BESG ScoreESG Rating

Price Chart

Stock Price Today

Bioventus Inc. (BVS) stock declined over -4.09%, trading at $7.50 on NASDAQ, down from the previous close of $7.82. The stock opened at $7.77, fluctuating between $7.33 and $7.69 in the recent session.

Stock Snapshot

7.82
Prev. Close
7.77
Open
496.18M
Market Cap
66.16M
Number of Shares
7.33
Day Low
7.685
Day High
-14.42
P/E Ratio
68.28%
Free Float in %
-0.52
EPS (TTM)
2.75
Book Value
0.13
Cash Flow per Share
244.68K
Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing DateAccepted Date

Annual Report (10-k)

Filing DateAccepted Date

Stock Price History Chart

DateOpenHighLowCloseVolume
Apr 21, 20257.717.847.337.50261.79K
Apr 17, 20257.747.887.597.82306.79K
Apr 16, 20257.687.987.567.78303.25K
Apr 15, 20257.908.147.617.74429.62K
Apr 14, 20257.698.147.587.92370.28K
Apr 11, 20257.467.677.137.48306.47K
Apr 10, 20257.907.907.407.57301.24K
Apr 09, 20257.508.377.267.95479.13K
Apr 08, 20258.668.667.547.65397.06K
Apr 07, 20257.798.577.558.27586.39K
Apr 04, 20258.928.928.168.33350.72K
Apr 03, 20259.109.188.819.15419.76K
Apr 02, 20259.319.569.169.51218.3K
Apr 01, 20259.119.388.909.37259.24K
Mar 31, 20258.949.258.869.15571.82K
Mar 28, 20259.139.188.789.03251.47K
Mar 27, 20259.119.268.979.09209K
Mar 26, 20259.449.539.079.12175.71K
Mar 25, 20259.749.989.389.43231.43K
Mar 24, 20259.709.919.669.72116.55K

Contact Details

Durham, NC 27703

United States

Website: https://www.bioventus.comContact: 919 474 6700

About Company

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Company Information

Employees930
Beta0.92
Sales or Revenue$512.35M
5Y Sales Change%0.456%
Fiscal Year EndsDecember
SectorHealthcare
IndustryMedical - Devices

Frequently Asked Questions

What is the current Bioventus Inc. (BVS) stock price?
Bioventus Inc. (NASDAQ: BVS) stock price is $7.50 in the last trading session. During the trading session, BVS stock reached the peak price of $7.69 while $7.33 was the lowest point it dropped to. The percentage change in BVS stock occurred in the recent session was -4.09% while the dollar amount for the price change in BVS stock was -$0.32.
BVS's industry and sector of operation?
The NASDAQ listed BVS is part of Medical - Devices industry that operates in the broader Healthcare sector. Bioventus Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of BVS?
Mr. Anthony D'Adamio
Senior Vice President, Gen. Counsel & Corporation Sec.
Ms. Katrina J. Church
Senior Vice President & Chief Compliance Officer
Mr. Anthony James
Vice President of Operations and Quality
Ms. Helen Leupold
Senior Vice President & Chief HR Officer
Mr. Mark Singleton
Senior Vice President, Chief Financial Officer & Principal Accounting Officer
Ms. Katrina J. Church J.D.
Senior Vice President & Chief Compliance Officer
Mr. Mark L. Singleton
Senior Vice President & Chief Financial Officer
Mr. Jeff Welch
Vice President of Bus. Devel.
Mr. Larry Chen
Managing Director of China & Asia Pacific
Mr. Kenneth M. Reali
Chief Executive Officer & Director
Mr. Leigh Ann Stradford
Senior Vice President & Chief HR Officer
Dr. Peter J. Shaw M.D.
Vice President of Medical Affairs & Chief Medical Officer
Mr. Miguel O. Beltran-Delgado
Senior Vice President of Operations
Ms. Alessandraa Pavesio
Senior Vice President & Chief Science Officer
Mr. Christopher K. Yamamoto
Senior Vice President of Corporation Devel. & Strategy
Ms. Sharon W. Klugewicz
Senior Vice President of Quality & Regulatory Affairs
Mr. Anthony P. Bihl III
Interim Chief Executive Officer & Director
How BVS did perform over past 52-week?
BVS's closing price is 92.31% higher than its 52-week low of $3.90 where as its distance from 52-week high of $14.38 is -47.84%.
How many employees does BVS have?
Number of BVS employees currently stands at 930.
Link for BVS official website?
Official Website of BVS is: https://www.bioventus.com
How do I contact BVS?
BVS could be contacted at phone 919 474 6700 and can also be accessed through its website. BVS operates from 4721 Emperor Boulevard, Durham, NC 27703, United States.
How many shares of BVS are traded daily?
BVS stock volume for the day was 244.68K shares. The average number of BVS shares traded daily for last 3 months was 323.76K.
What is the market cap of BVS currently?
The market value of BVS currently stands at $496.18M with its latest stock price at $7.50 and 66.16M of its shares outstanding.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph